STATE OF WISCONSIN INVESTMENT BOARD - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 255 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,293,865
-27.1%
85,369
-3.3%
0.01%
-22.2%
Q2 2023$3,148,421
+33.2%
88,290
-5.1%
0.01%
+28.6%
Q1 2023$2,363,318
-42.2%
93,044
-7.7%
0.01%
-46.2%
Q4 2022$4,089,949
+20.7%
100,837
-1.6%
0.01%
+18.2%
Q3 2022$3,388,000
-10.7%
102,526
-4.9%
0.01%
+10.0%
Q2 2022$3,796,000
-39.2%
107,821
-20.6%
0.01%
-23.1%
Q1 2022$6,245,000
-30.6%
135,8000.0%0.01%
-23.5%
Q4 2021$9,004,000
+5.9%
135,800
-0.3%
0.02%
-5.6%
Q3 2021$8,503,000
-23.8%
136,200
+1.0%
0.02%
-21.7%
Q2 2021$11,164,000
+22.2%
134,800
-2.2%
0.02%
+21.1%
Q1 2021$9,138,000
-15.4%
137,800
-2.1%
0.02%
-24.0%
Q4 2020$10,796,000
+55.7%
140,700
-12.6%
0.02%
+47.1%
Q3 2020$6,933,000
-0.3%
161,0000.0%0.02%
-10.5%
Q2 2020$6,954,000
+56.3%
161,000
+4.1%
0.02%
+26.7%
Q1 2020$4,448,000
-49.8%
154,600
+10.7%
0.02%
-31.8%
Q4 2019$8,855,000
+125.1%
139,6000.0%0.02%
+100.0%
Q3 2019$3,934,000
+9.1%
139,600
+2.6%
0.01%
+10.0%
Q2 2019$3,607,000
+61.0%
136,100
+11.5%
0.01%
+66.7%
Q1 2019$2,241,000
+100.4%
122,100
+35.7%
0.01%
+50.0%
Q4 2018$1,118,000
-34.2%
90,000
+1.5%
0.00%
-20.0%
Q3 2018$1,700,000
+41.0%
88,7000.0%0.01%
+66.7%
Q2 2018$1,206,00088,7000.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q1 2023
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,264$54,392,00033.22%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$216,228,00028.00%
L1 Capital Pty Ltd 296,024$19,629,0004.93%
Aquilo Capital Management, LLC 407,926$27,050,0004.89%
Evolutionary Tree Capital Management, LLC 72,948$4,837,0002.86%
ACUTA CAPITAL PARTNERS, LLC 108,000$7,161,0002.58%
First Light Asset Management, LLC 536,836$35,598,0002.36%
Parkman Healthcare Partners LLC 70,089$4,648,0001.08%
Hood River Capital Management LLC 357,082$23,678,0000.76%
Vanguard Capital Wealth Advisors 11,099$703,565,0000.60%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders